We are live on
!
Find out more
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SO
51
STRS Ohio
Columbus,
Ohio
| $41K | +$40.3K | +1,900 | New |
|
|
AIM
52
ARK Investment Management
St. Petersburg,
Florida
| $40K | +$38.4K | +1,811 | New |
|
53
Barclays
London,
United Kingdom
| $31K | +$29.7K | +1,400 | New |
|
54
Legal & General Group
London,
United Kingdom
| $27K | +$26.1K | +1,230 | New |
|
55
Bank of America
Charlotte,
North Carolina
| $26K | +$24.6K | +1,162 | New |
|
56
UBS Group
Zurich,
Switzerland
| $24K | +$23.5K | +1,110 | New |
|
|
AIP
57
Ameritas Investment Partners
Lincoln,
Nebraska
| $14K | +$13.1K | +620 | New |
|
58
Royal Bank of Canada
Toronto,
Ontario, Canada
| $9K | +$8.47K | +400 | New |
|
|
FMA
59
FNY Managed Accounts
New York
| $9K | +$9.32K | +440 | New |
|